valneva se glp-1 receptor agonist weight management diabetes treatments New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within Agonists GLP-1 Receptor Agonists as Treatments

Industry Report Examines What Consumers Are Searching For After Seeing Weight Loss Patch Ads, What These Products Actually Contain, and How to Evaluate Non-Prescription Options Entering 2026NEW YORK, Dec

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.

This review provides a meticulous exploration of GLP-1, elucidating its origin, secretion, and the challenges associated with its clinical application due to its fragility in the presence of DPP-IV, resulting in a short half-life

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

This review delves into the physiological roles of GLP-1, exploring its impact on ...